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Objective: Motion-corrected averaging with a single-shot technique was introduced for faster acquisition of late-gadolinium-
enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging while free-breathing. We aimed to evaluate the image 
quality (IQ) of free-breathing motion-corrected single-shot LGE (moco-ss-LGE) in patients with hypertrophic cardiomyopathy 
(HCM).
Materials and Methods: Between April and December 2019, 30 patients (23 men; median age, 48.5; interquartile range 
[IQR], 36.5–61.3) with HCM were prospectively enrolled. Breath-held single-shot LGE (bh-ss-LGE) and free-breathing moco-
ss-LGE images were acquired in random order on a 3T MR system. Semi-quantitative IQ scores, contrast-to-noise ratios (CNRs), 
and quantitative size of myocardial scar were assessed on pairs of bh-ss-LGE and moco-ss-LGE. The mean ± standard deviation 
of the parameters was obtained. The results were compared using the Wilcoxon signed-rank test. 
Results: The moco-ss-LGE images had better IQ scores than the bh-ss-LGE images (4.55 ± 0.55 vs. 3.68 ± 0.45, p < 0.001). 
The CNR of the scar to the remote myocardium (34.46 ± 11.85 vs. 26.13 ± 10.04, p < 0.001), scar to left ventricle (LV) cavity 
(13.09 ± 7.95 vs. 9.84 ± 6.65, p = 0.030), and LV cavity to remote myocardium (33.12 ± 15.53 vs. 22.69 ± 11.27, p < 0.001) 
were consistently greater for moco-ss-LGE images than for bh-ss-LGE images. Measurements of scar size did not differ 
significantly between LGE pairs using the following three different quantification methods: 1) full width at half-maximum 
method; 23.84 ± 12.88% vs. 24.05 ± 12.81% (p = 0.820), 2) 6-standard deviation method, 15.14 ± 10.78% vs. 15.99 ± 
10.99% (p = 0.186), and 3) 3-standard deviation method; 36.51 ± 17.60% vs. 37.50 ± 17.90% (p = 0.785).
Conclusion: Motion-corrected averaging may allow for superior IQ and CNRs with free-breathing in single-shot LGE imaging, 
with a herald of free-breathing moco-ss-LGE as the scar imaging technique of choice for clinical practice.
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MATERIALS AND METHODS
The Institutional Review Board of Chung-Ang university 
hospital approved this prospective study, and written 
informed consent was obtained from all participants before 
CMR acquisition (IRB No. 1801-011-346).
Study Population
Between April and December 2019, 35 patients initially 
recorded as having HCM on echocardiography underwent 
gadolinium-enhanced CMR for the evaluation of HCM at 
our institution. Among the 35 patients, those who agreed 
to the additional acquisition of moco-ss-LGE during CMR 
acquisition were enrolled in this study. Patients were 
required to be ≥ 18 years of age, with no contraindications 
to gadolinium contrast agents, inclusive of an estimated 
glomerular filtration rate of > 60 mL/min/1.73 m2. Patients 
with a history of percutaneous coronary intervention and 
implantable cardiac devices were excluded during screening. 
Finally, 32 patients with HCM underwent CMR, including 
both moco-ss-LGE and bh-ss-LGE, while two patients were 
excluded because one had an unrecognized myocardial 
infarction (MI) and the other was confirmed not to have 
HCM (maximal myocardial thickness less than 15 mm) 
on CMR. Finally, 30 patients (23 men; median age, 48.5; 
interquartile range [IQR], 36.5–61.3) were included in our 
study (Fig. 1).
Acquisition of CMR
All patients underwent CMR at 3T (MAGNETOM Skyra, 
INTRODUCTION
The introduction of late-gadolinium-enhancement (LGE) 
images on cardiovascular magnetic resonance (CMR) allows 
for the assessment of myocardial replacement fibrosis and 
scarring [1,2]. With a growing body of evidence indicating 
that the presence and extent of LGE are associated with 
poor prognosis in various diseases, LGE on CMR has been 
applied to a wide variety of indications in clinical cardiology 
[3,4]. In terms of hypertrophic cardiomyopathy (HCM), 
LGE was listed as a potential risk modifier for sudden 
cardiac death and a predictor of cardiovascular mortality in 
professional guidelines [5-9].
The standard technique for LGE acquisition is a 
segmented phase-sensitive inversion recovery (PSIR) 
sequence with breath-holding. Segmented PSIR LGE 
generally provides satisfactory image quality, based on good 
patient cooperation and a stable heartbeat as prerequisites 
[10]. With the widespread use of CMR in clinical practice, 
however, the need for LGE acquisition in patients with 
arrhythmias or an inability to maintain adequate breath-
holding has increased. In these patients, breathing and an 
irregular heartbeat may lead to modulation of signal and 
ghosting artifacts, thus hindering the precise interpretation 
of myocardial fibrosis [11]. Furthermore, reducing the scan 
time is another critical issue for CMR.
To overcome these issues, single-shot LGE was introduced. 
Given that one LGE slice can be acquired within one cardiac 
cycle, this technique is highly useful in patients with 
arrhythmias and difficulty in multiple breath-holding and 
also increases the patient throughput of the MR system. 
However, this scan-time reduction comes at the cost of 
a lower signal-to-noise ratio (SNR) and decreased spatial 
resolution. Fortunately, parallel imaging reconstruction 
has enabled single-shot LGE without compromising spatial 
resolution. Further, multiple images may be registered 
and averaged to enhance the SNR without discernible 
respiration-related motion blurring, which is known as 
motion-corrected averaging [12,13].
In this prospective study, we aimed to evaluate the image 
quality of free-breathing motion-corrected single-shot LGE 
(moco-ss-LGE) in comparison with breath-held single-shot 
LGE (bh-ss-LGE) in patients with HCM. We hypothesized that 
image quality and diagnostic confidence of moco-ss-LGE 
would be superior to that of bh-ss-LGE without a discernible 
difference in quantitative scar size measurement. Fig. 1. Patient enrollment. HCM = hypertrophic cardiomyopathy, IQR = interquartile range, moco-ss-LGE = motion-corrected single-shot 


















35 patients with HCM, planning for gadolinium-enhanced  
  cardiac MRI between April and December of 2019
• History of percutaneous coronary intervention (n = 1)
• Implantable cardiac device (n = 2)
• Unrecognized myocardial infarction (n = 1)
• Not satisfying diagnostic criteria of HCM on MRI (n = 1)
32 eligible patients who agreed for additional acquisition of  
  the free-breathing moco-ss-LGE during cardiac MRI
30 patients finally enrolled (23 male; median age, 48.5;  




Siemens Healthineers), and a detailed CMR protocol is listed 
in the Supplementary Materials.
The bh-ss-LGE and free-breathing moco-ss-LGE sequences 
were performed in random order to avoid systematic bias 
caused by differences in contrast washout. LGE acquisition 
was initiated 10 minutes after contrast administration by 
short-axis slices covering the full left ventricle (LV). Each 
LGE image was obtained after obtaining scout images using 
an inversion recovery turbo fast low-angle shot sequence, 
and reconstructions were performed using PSIR. The detailed 
parameters for the two LGE sequences were as follows: 1) 
bh-ss-LGE: field of view (FOV) of 363 x 272 mm, 8 mm slice 
thickness with 2 mm slice gap, image matrix of 256 x 144, 
repetition time (TR)/echo time (TE) of 2.5/1.06 ms, pixel 
bandwidth of 1184 Hz, acceleration factor (GRAPPA) of 2, 
number of excitations (NEX) of 1, 72 lines per segment, and 
a flip angle of 40°; and 2) free-breathing moco-ss-LGE: FOV 
of 363 x 272 mm, 8 mm slice thickness with 2 mm slice 
gap, image matrix of 256 x 144, TR/TE of 2.8/1.18 msec, 
pixel bandwidth of 1085 Hz, acceleration factor (GRAPPA) 
of 2, NEX of 1, and a flip angle of 40°. bh-ss-LGE sequences 
were acquired during breath-holding during end-expiration, 
and two or three breath-holds were required for the entire 
slice acquisition. For free-breathing moco-ss-LGE, each 
acquisition involved eight repeated measurements per slice 
with measurements performed at every second RR interval 
for a duration of 16 heartbeats [12]. Fully automated in-
plane respiratory motion compensation was achieved by 
performing independent non-rigid registration processes 
to a reference frame with respect to all other frames in 
the complete set of acquired images. Each independent 
registration step implemented an optimization procedure 
that minimizes a similarity measure of the two images to 
identify the best transformation that maps a given frame 
into the frame of reference described previously, which 
represents an image-based navigator scheme [14]. 
Quantitative Image Quality Analysis
The quantitative analysis was independently performed by 
two observers (a board-certified radiologist and cardiologist 
with 6 and 12 years of cardiac multimodality imaging 
experience, respectively). Regions of interest (ROIs) were 
drawn in the LV blood pool, a remote area of the normal 
myocardium, and the area of hyperenhancement to obtain 
signals from the respective tissues. Image noise was defined 
as the standard deviation (SD) of the signal intensity in 
the normal-appearing remote myocardium. The contrast-
to-noise ratio (CNR) was calculated as the ratio of the 
difference in the mean signal intensity between ROIs and 
the image noise. The CNR was calculated for the difference 
between the scar and the blood pool (CNRscar-blood), between 
the scar and the myocardium (CNRscar-myo), and between the 
blood and the remote myocardium (CNRblood-myo). As PSIR 
reconstruction fundamentally implements the process of 
spatial smoothing to reduce the noise of reference images, 
the background noise measured on PSIR images does not 
indicate the true value. Thus, we did not perform an SNR 
assessment.
Qualitative Image Quality Analysis
Two experienced observers (board-certified radiologists 
with 6 and 12 years of CMR experience, respectively) 
reviewed the images independently. We used subjective 
image quality ratings as follows: 1 = very poor and not 
analyzable; 2 = poor; 3 = acceptable; 4 = good; and 5 = very 
good. We also rated the degree of observer confidence with 
regard to the presence or absence of myocardial scarring 
as 1 = low confidence, 2 = some confidence, and 3 = high 
confidence [11,15].
Myocardial Scar Size Measurement
LGE quantification was performed using dedicated 
software (Circle Cardiovascular Imaging 4.2, Circle 
Cardiovascular Imaging) by a radiologist (with 6 years 
of experience in CMR) blinded to the image acquisition 
technique. The hyperenhanced myocardium was 
automatically segmented using three different methods: 1) 
the full width at half-maximum (FWHM; threshold of 50% 
of the maximum intensity within the scar), 2) the 3-SD and 
3) the 6-SD methods, which define LGE as the myocardial 
signal intensity plus 3 or 6 SDs above that of the normal-
appearing myocardium, respectively [16,17]. The percentage 
of fibrous tissue mass to the total myocardial LV mass was 
calculated.
Statistical Analysis
For sample size calculation, preliminary images were 
obtained from six volunteers who were not included in the 
final study population. The average image quality scores ± 
SD by two independent readers for two sets of LGE images 
were 4.42 ± 0.66 and 3.58 ± 0.49, respectively. We found 
that at least 30 subjects were required in order to obtain 
a power of 80% and a two-sided α-level of 0.05, with an 
effect size of 0.58, considering a dropout rate of 10%.
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Patient characteristics are shown in Table 1. The median 
patient body surface area was 1.80 (IQR, 1.66–1.97), and 
the median heart rate during CMR acquisition was 59 bpm 
(IQR, 57–67). Seven patients (23.3%) experienced atrial 
fibrillation (four persistent and three paroxysmal atrial 
fibrillation). The mean acquisition time ± SD for moco-ss-
LGE was 180.8 ± 38.7 seconds. For bh-ss-LGE, it was 57.9 
± 17.8 seconds, together with breath-hold voice commands 
and breathing cycles between the image acquisition 
periods. The number and level of slices for both LGE pairs 
were identical, ranging from 9 to 15, according to the LV 
chamber size.
Quantitative Image Quality
There were no significant differences in CNR values 
between the measurements obtained by the two observers, 
and the interobserver agreement was as follows: ICC for 
CNRblood-myo = 0.797 (95% confidence interval [CI], 0.547–
0.909; p < 0.001), ICC for CNRscar-blood = 0.885 (95% CI, 
0.733–0.950; p < 0.001), and ICC for CNRscar-myo = 0.877 (95% 
CI, 0.716–0.927; p < 0.001). Thus, the mean values of both 
observers’ measurements were used for further calculations. 
Table 2 illustrates that the CNRs were significantly higher 
in moco-ss-LGE images than in bh-ss-LGE images. The CNR 
of the scar to the remote myocardium (mean ± SD, 34.46 
± 11.85 vs. 26.13 ± 10.04, p < 0.001), scar to LV cavity 
(13.09 ± 7.95 vs. 9.84 ± 6.65, p = 0.030), and LV cavity to 
remote myocardium (33.12 ± 15.53 vs. 22.69 ± 11.27, p < 
0.001) were consistently greater for moco-ss-LGE than for 
bh-ss-LGE. When we performed subgroup analysis in seven 
patients with atrial fibrillation, CNRblood-myo (31.89 ± 9.76 vs. 
24.76 ± 7.60, p = 0.043) and CNRscar-myo (26.05 ± 8.79 vs. 
19.99 ± 5.02, p = 0.018) were significantly higher in moco-
ss-LGE images than in bh-ss-LGE images (Supplementary 
Table 2). The CNR measurements in both LGE images were 
lower in patients with atrial fibrillation than in those 
without; however, this difference was not statistically 
significant (Supplementary Table 3).
Semi-quantitative image quality scores and CNRs, 
diagnostic confidence scores, scan times, and scar tissue 
percentages were compared using the Wilcoxon signed-
rank test. Bland-Altman analysis and Spearman correlation 
analysis were used to evaluate the agreement of LGE size 
assessed by both techniques. The kappa statistic was used 
for interobserver agreement of the qualitative image quality 
and confidence scores. The agreement was categorized 
as slight (0.00–0.20), fair (0.21–0.40), moderate 
(0.41–0.60), substantial (0.61–0.80), and almost perfect 
(0.81–1.00) [18,19]. The intraclass correlation coefficient 
(ICC) was obtained for interobserver agreement of the 
CNR measurements. A p value of < 0.05 was considered 
statistically significant. All statistical analyses were 
performed using SPSS statistics for windows version 20.0 
(IBM Corp.) and software dedicated to statistical power 
analysis (G*Power version 3.1.9.6).
RESULTS
Baseline Characteristics and Acquisition Time
All 30 patients were examined successfully. Sixteen 
patients underwent bh-ss-LGE first followed by moco-ss-
LGE, and the remaining 14 patients underwent imaging 
in the opposite order. The qualitative image quality and 
diagnostic confidence did not differ significantly according 
to the scan order of the LGEs (Supplementary Table 1). 
Table 1. Clinical Characteristics of the Study Population
Characteristics Values
Age, years* 48.5 (36.5–61.3)
Sex, male:female 23:7
HCM subtypes
Apical HCM 14 (46.7)
Asymmetric septal HCM 11 (36.7)
Mixed HCM 5 (16.6)
Atrial fibrillation 7 (23.3)
CMR findings*
Maximal ED wall thickness, mm 18 (15.8–20.3)
LV mass index, g/m2 89.7 (78.8–116.5)
LVEDVi, mL/m2 71.5 (60.9–83.4)
LVESVi, mL/m2 27.3 (18.9–32.0)
LV ejection fraction, % 64.8 (58.5–69.0)
Data are number of patients with corresponding percentage in the 
parentheses, unless specified otherwise. *Median (interquartile 
range). CMR = cardiac magnetic resonance, ED = end-diastolic, 
HCM = hypertrophic cardiomyopathy, LV = left ventricle, LVEDVi = left 
ventricular end-diastolic volume index, LVESVi = left ventricular 
end-systolic volume index
Table 2. Comparison of CNRs on Pairs of LGE Images
bh-ss-LGE moco-ss-LGE P
CNRblood-myo 26.13 ± 10.04 34.46 ± 11.85 < 0.001
CNRscar-blood 9.85 ± 6.65 13.09 ± 7.94 0.030
CNRscar-myo 22.69 ± 11.27 33.12 ± 15.53 < 0.001
Data are mean ± standard deviation. bh-ss-LGE = breath-held 
single-shot LGE, CNR = contrast-to-noise ratio, LGE = late-
gadolinium-enhancement, moco-ss-LGE = motion-corrected single-





Examples of image quality for bh-ss-LGE and moco-
ss-LGE acquisitions are presented in Figure 2. Figure 3 
shows representative LGE images from patients with atrial 
fibrillation. Table 3 summarizes the results of the image 
quality scoring by both readers. The image quality scores 
differed significantly between the moco-ss-LGE and bh-ss-
LGE images. The moco-ss-LGE images received higher image 
quality scores than the bh-ss-LGE images (average scores of 
two readers ± SD, 4.55 ± 0.55 vs. 3.68 ± 0.45, respectively, 
p < 0.001). LGE was detected in 28 of 30 patients on 
both LGE images, with 100% agreement between the 
two readers. In terms of diagnostic confidence for LGE 
detection, there was no significant difference between LGE 
image pairs (average scores of two readers ± SD, 2.85 ± 0.48 
vs. 2.82 ± 0.50, p = 0.710). The interobserver agreement 
for qualitative image quality assessment was substantial 
to almost perfect (κ = 0.683 for overall image quality and 
κ = 0.844 for diagnostic confidence). Subgroup analysis of 
seven patients with atrial fibrillation revealed consistent 
findings in the image quality and diagnostic confidence 
scores for LGE pairs, as demonstrated in Supplementary 
Table 4. 
Myocardial Scar Size Measurement





Fig. 2. Representative image pairs of bh-ss-LGE and moco-ss-LGE.
A-D. bh-ss-LGE images (A, B) and free-breathing moco-ss-LGE (C, D) images in (A, C) a 49-year-old male patient and (B, D) a 64-year-old 
male patient with hypertrophic cardiomyopathy, respectively. Homogenous signal intensity of the blood and the remote myocardium, resulting 
in better visualization of LGE, is noted on moco-ss-LGE, compared to bh-ss-LGE. The papillary muscles and trabeculae are also more clearly 
demarcated from the left ventricle cavity and endocardial border on moco-ss-LGE than on bh-ss-LGE. bh-ss-LGE = breath-held single-shot LGE, 
LGE = late-gadolinium-enhancement, moco-ss-LGE = motion-corrected single-shot LGE
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Table 3. Semi-Quantitative Analysis of the Image Quality of Pairs of LGE Images
Parameter
Scoring
Mean ± SD Kappa* (P) P
1 2 3 4 5
Overall image quality
bh-ss-LGE
Reader 1 0 0 12 17 1 3.63 ± 0.56 0.683 (< 0.001) < 0.001
Reader 2 0 0 8 22 0 3.73 ± 0.45
moco-ss-LGE
Reader 1 0 0 0 3 24 4.47 ± 0.68
Reader 2 0 0 1 9 20 4.63 ± 0.56
Parameter
Scoring




Reader 1 1 3 26 2.83 ± 0.46 0.844 (< 0.001) 0.326
Reader 2 2 2 26 2.80 ± 0.55
moco-ss-LGE
Reader 1 1 2 27 2.87 ± 0.43
Reader 2 2 1 27 2.83 ± 0.53
*Interobserver variability between two readers for each parameter. bh-ss-LGE = breath-held single-shot LGE, LGE = late-gadolinium-
enhancement, moco-ss-LGE = motion-corrected single-shot LGE, SD = standard deviation
Fig. 3. Representative LGE imges of patients with hypertrophic cardiomyopathy with atrial fibrillation. bh-ss-LGE images (upper row) 
and free-breathing moco-ss-LGE images (lower row) obtained from hypertrophic cardiomyopathy patients with atrial fibrillation. The papillary 
muscles, trabeculae, and endocardial border are more clearly distinguished from the left ventricle cavity, and the myocardial scar (enhanced 
area) is more obviously demarcated from the remote myocardium on moco-ss-LGE than on bh-ss-LGE. bh-ss-LGE = breath-held single-shot late-




between the pairs of LGE images by the FWHM method (mean 
± SD, 23.84 ± 12.88% vs. 24.05 ± 12.81%; p = 0.820), the 
6-SD method (15.14 ± 10.78% vs. 15.99 ± 10.99%; p = 
0.186), or the 3-SD method (36.51 ± 17.60% vs. 37.50 ± 
17.90%; p = 0.785) (Table 4, Fig. 4). Spearman correlation 
analyses revealed an excellent correlation of the relative 
scar size between the LGE pairs using the FWHM technique 
(rho = 0.946, p < 0.001), 6-SD method (rho = 0.945, p < 
0.001), and 3-SD method (rho = 0.916, p < 0.001). In the 
Bland-Altman plot analysis, none of the cases were outside 
the 95% limits of agreement with the use of the FWHM 
method. For the 6-SD and 3-SD methods, 2 (2/30; 6.7%) 
and 1 (1/30; 3.3%) of 30 cases were outside the limits of 
agreement, respectively (Fig. 5). In the subgroup analysis 
of patients with atrial fibrillation, a good correlation of the 
relative scar size between the LGE pairs was still observed 
using the FWHM method (rho = 0.919, p = 0.003), 6-SD 
method (rho = 0.893, p = 0.007), and 3-SD method (rho = 
0.857, p = 0.014).
DISCUSSION
This prospective study demonstrated the superiority of 
the free-breathing moco-ss-LGE sequence over the bh-ss-
LGE sequence in HCM patients referred for clinical CMR. The 
main finding of our study was that free-breathing moco-
ss-LGE outperformed bh-ss-LGE in terms of qualitative and 
quantitative image quality. The scar size did not differ 
significantly between moco-ss-LGE and bh-ss-LGE based on 
three different quantification methods (FWHM, 3-SD, 6-SD). 
In addition, these findings were consistently observed in 
patients with arrhythmia (7/30; 23.3%).
Theoretically, the CNR for the images with eight 
averages is improved by √8 [12]. Our real-world data also 
demonstrated that the CNR values obtained from moco-
ss-LGE images were significantly and persistently higher 
than those from bh-ss-LGE images. This improved contrast 
between the scar and the normal myocardium may enable 
intuitive visualization and analysis of myocardial fibrosis, 
even for inexperienced clinicians. In addition, improved 
Table 4. Quantitative Assessment of Relative Myocardial Scar 
Size (%)
bh-ss-LGE moco-ss-LGE P
FWHM 23.84 ± 12.88 24.05 ± 12.81 0.820
3-SD 36.51 ± 17.60 37.50 ± 17.90 0.285
6-SD 15.14 ± 10.78 15.99 ± 10.99 0.186
Data are mean ± SD. bh-ss-LGE = breath-held single-shot late-
gadolinium-enhancement, FWHM = full width half-maximum, 
moco-ss-LGE = motion-corrected single-shot late-gadolinium-













Fig. 4. Comparison between the methods of LGE quantification in a 21-year-old male with asymmetric septal hypertrophic 
cardiomyopathy. Relative infarct size was quantified by identifying myocardial area with LGE, overlaid with yellow, using the FWHM, 6-SD, or 
3-SD method. Infarct size measures on bh-ss-LGE and moco-ss-LGE were 36.1% and 38.6% with the FWHM method, 19.2% and 21.1% with the 
6-SD method, and 39.1% and 39.8% with the 3-SD method, respectively. bh-ss-LGE = breath-hold single-shot LGE, FWHM = full width at half-
maximum, LGE = late-gadolinium-enhancement, moco-ss-LGE = motion-corrected single-shot LGE, SD = standard deviation
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scar-to-blood pool contrast may increase subendocardial 
scar conspicuity, potentially improving detection of 
small subendocardial infarction in patients with ischemic 
cardiomyopathy. Regarding scan speed, the acquisition time 
for the moco-ss-LGE sequence was 2.91 ± 0.43 minutes, 
which is similar to that of previous reports using eight 
repeated measurements per slice [15,20,21]. Although the 
acquisition time for the moco-ss-LGE sequence was longer 
than that of the bh-ss-LGE sequence without averaging, 
it is still almost half of the scan time for conventional 
segmented LGE, which was reported to require 5–10 minutes 
to cover the LV [15,21,22].
Arrhythmia is a common clinical presentation in various 
cardiomyopathies, including HCM, in which CMR can 
play a role in disease evaluation and prognostication. In 
such cases, single-shot imaging should be recommended 
over conventional segmented imaging in order to avoid 
ghosting artifacts [23,24]. Our study contributes to the 
growing body of literature on the robustness of single-shot 
technique and motion-correction algorithm for arrhythmia 
by demonstrating comparable image quality and scar size 
measures in patients with atrial fibrillation. In addition, the 
motion-correction algorithm utilized in the present study 
suppresses artifacts caused by respiratory movements [25]. 
Our results suggest that free-breathing moco-ss-LGE can be 
utilized as the scar imaging technique of choice for various 
cardiac diseases in routine clinical practice, which may 
broaden the application of CMR.
To date, there have been several studies comparing free-
breathing moco-ss-LGE with conventional segmented PSIR 
LGE using a 1.5T MR system. A previous study by Piehler 
et al. [15] was the first to report on the superiority of 
free-breathing moco-ss-LGE over the conventional breath-
hold segmented LGE in a patient with MI. A recent 
study by Captur et al. [21] also demonstrated that free-
breathing moco-ss-LGE provides better images and higher 
diagnostic performance than breath-hold segmented LGE, 
by performing a real-world CMR study in 400 consecutive 
patients. Additionally, Fan et al. [20] reported that moco-
ss-LGE is a robust scar imaging technique, based on the 
result of a direct comparison between moco-ss-LGE and 
traditional breath-hold segmented LGE. Our work further 
validated the robustness of moco-ss-LGE using a 3T MR 
scanner in patients with HCM. Moreover, the current study 
differs from prior studies in that we focused on single-shot 
technique by comparing single-shot LGE images with and 
without motion-corrected averaging.
Fig. 5. Bland-Altman plots illustrate good agreement across 
the LGE size spectrum between bh-ss-LGE and free-breathing 
moco-ss-LGE images. Solid and dotted lines indicate the mean 
difference and ± 1.96 SD of the differences, respectively. bh-ss-LGE = 
breath-hold single-shot LGE, FWHM = full width at half-maximum, 
LGE = late-gadolinium-enhancement, moco-ss-LGE = motion-corrected 




































10 20 30 40 50



































10 20 30 40 50




































10 20 30 40 50 60





Our study demonstrated that there is no significant 
difference in scar size between single-shot LGE with and 
without motion-corrected averaging. We calculated LGE 
masses using three different quantification methods: 
FWHM, 3-SD, and 6-SD methods. Many previous studies 
have demonstrated highly correlated LGE masses between 
conventional segmented LGE and free-breathing moco-
ss-LGE [15,20,21]. The current study also expanded the 
spectrum of reliable LGE imaging techniques for myocardial 
scar quantification.
This study has several limitations. First, it was limited 
by its single-center design with a single manufacturer of 
MR systems (Siemens Healthineers). Second, the number 
of patients was relatively small. Nonetheless, our study 
subjects were a purely clinical population with HCM and 
may reflect real-world practice. Further studies with 
patients with ischemic cardiomyopathy can have clinical 
implications, as detection of even small myocardial scars 
is prognostically important in patients with previous MI 
[26]. Third, we only compared short-axis slices for each 
LGE sequence. The robustness of the motion-correction 
algorithm on different orientations, such as two- or four-
chamber views, should still be explored. Lastly, we did 
not perform conventional segmented LGE imaging as a 
standard reference technique for image quality evaluation 
and myocardial scar quantification. However, many previous 
studies have compared conventional segmented LGE and 
free-breathing moco-ss-LGE and showed that moco-ss-LGE 
is reliable for scar quantification with better image quality 
over segmented LGE. In addition, the use of single-shot LGE 
has been increasing, especially for those with arrhythmias 
or an inability to maintain adequate breath-holding.
In conclusion, the current study indicated that moco-
ss-LGE is a feasible and robust sequence for LGE imaging, 
yielding superior image quality and similar scar size 
measurement compared to bh-ss-LGE in patients with HCM. 
We suggest that free-breathing moco-ss-LGE may be used 
as the scar imaging technique of choice for routine clinical 
practice.
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